27/02/201726/01/2024 Helix Biopharma Corp. Announces Licence for Worldwide Right to Anti-CEACAM6 Antibody from the Government of Canada admin 0 Comments
22/02/201726/01/2024 30mil CAD$ Investment in European Centre of Cancer Immunotherapy admin 0 Comments
02/02/201726/01/2024 Helix Biopharma Corp. to Present at the BIO CEO & Investor Conference in New York admin 0 Comments